Xarelto (chemical name Rivaroxaban) is an anti-coagulant manufactured by Bayer typically prescribed for people who are at risk for nonhemorrhagic strokes or embolisms. It has also been FDA approved for use during total knee or hip replacement surgery, as well as non-valvular atrial fibrillation. The FDA first approved Rivaroxaban for use in the United States in 2011.
Because it is an anticoagulant, Xarelto poses a serious risk of uncontrolled bleeding, including internal bleeding. At present, there is no known way to reverse the effects of Xarelto, which may be active for 8-12 hours. The FDA has also received reports of liver toxicity tied to use of Xarelto and has required that the package contain a warning not to discontinue without talking to a physician, as the likelihood of stroke can increase dramatically.
If you or someone you love has suffered injury after being prescribed Xarelto, contact the attorneys at Bailey & Galyen online or call our office at 1-800-216-2525 for a free initial consultation.
Defective Drugs & Medical Devices Topics
Pre-Nuptial Agreements in New York: Doing Them Correctly!
There can be a variety of reasons for individuals entering into a pre-nuptial agreement. However unless a pre-nuptial agreement.... Read More
What to Do if CPS Contacts You
Written By: Attorney Elliot S. Schlissel To start with ask the investigator why they are investigating you. The investigators job.... Read More
Statement of Clients Rights and Responsibilities
The New York State Bar Association has promulgated documents called the Statements of Client’s Rights and Responsibilities. It gives clients.... Read More